Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes

Stephen C.L. Gough; Anuj Bhargava; Rajeev Jain; Henriette Mersebach; Søren Rasmussen; Richard M. Bergenstal

doi:10.2337/dc12-2329

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc12-2329 ◽

2013 ◽

Vol 36 (9) ◽

pp. 2536-2542 ◽

Cited By ~ 101

Author(s):

Stephen C.L. Gough ◽

Anuj Bhargava ◽

Rajeev Jain ◽

Henriette Mersebach ◽

Søren Rasmussen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Insulin Degludec ◽

Low Risk ◽

Once Daily ◽

Low Volume

Download Full-text

200 U/ml Insulin Degludec Improves Glycemic Control Similar to Insulin Glargine with a Low Risk of Hypoglycemia in Insulin-naïve People with Type 2 Diabetes

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2012.07.397 ◽

2012 ◽

Vol 36 (5) ◽

pp. S57 ◽

Cited By ~ 7

Author(s):

Richard Bergenstal ◽

Anuj Bhargava ◽

Rajeev K. Jain ◽

Stuart A. Ross ◽

Azhar Rana ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Insulin Degludec ◽

Low Risk

Download Full-text

INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES

Endocrine Practice ◽

10.4158/ep171922.or ◽

2018 ◽

Vol 24 (2) ◽

pp. 143-149 ◽

Cited By ~ 5

Author(s):

Medha N. Munshi ◽

Jasvinder Gill ◽

Jason Chao ◽

Elena V. Nikonova ◽

Meenakshi Patel

Keyword(s):

Type 2 Diabetes ◽

Weight Gain ◽

Glycemic Control ◽

Insulin Glargine ◽

Aging Population ◽

Low Risk

Download Full-text

Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.)

Endocrinology and Metabolism ◽

10.3803/enm.2020.35.1.192 ◽

2020 ◽

Vol 35 (1) ◽

pp. 192

Author(s):

Sang Youl Rhee

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Aspart ◽

Basal Insulin ◽

Insulin Degludec ◽

Once Daily ◽

Daily Insulin

Download Full-text

The Effect of Insulin Degludec on Glycemic Control and Nocturnal Hypoglycemia Compared with Insulin Glargine: a 1-year Randomized Trial in Insulin-naïve People with Type 2 Diabetes

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2012.07.402 ◽

2012 ◽

Vol 36 (5) ◽

pp. S58

Author(s):

Bernard Zinman ◽

Athena Philis-Tsimikas ◽

Yehuda Handelsman ◽

Helena W. Rodbard ◽

Bertrand Cariou ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Nocturnal Hypoglycemia

Download Full-text

Insulin degludec versus insulin glargine, both once daily as add-on to existing orally administered antidiabetic drugs in insulin-naive Japanese patients with uncontrolled type 2 diabetes: subgroup analysis of a pan-Asian, treat-to-target phase 3 trial

Diabetology International ◽

10.1007/s13340-015-0221-3 ◽

2015 ◽

Vol 7 (2) ◽

pp. 141-147 ◽

Cited By ~ 3

Author(s):

T. Osonoi ◽

Y. Onishi ◽

T. Nishida ◽

J. Hyllested-Winge ◽

Y. Iwamoto

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Subgroup Analysis ◽

Japanese Patients ◽

Insulin Degludec ◽

Antidiabetic Drugs ◽

Treat To Target ◽

Phase 3 ◽

Once Daily

Download Full-text

Superior glycaemic control with once‐daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12097 ◽

2013 ◽

Vol 15 (9) ◽

pp. 826-832 ◽

Cited By ~ 41

Author(s):

Y. Onishi ◽

Y. Ono ◽

R. Rabøl ◽

L. Endahl ◽

S. Nakamura

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Insulin Degludec ◽

Oral Drugs ◽

Phase 3 ◽

Once Daily ◽

Randomized Controlled ◽

Japanese Adults

Download Full-text

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0163350 ◽

2016 ◽

Vol 11 (10) ◽

pp. e0163350 ◽

Cited By ~ 13

Author(s):

Ajay Kumar ◽

Edward Franek ◽

Jonathan Wise ◽

Marcus Niemeyer ◽

Henriette Mersebach ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Insulin Aspart ◽

Controlled Trial ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Once Daily ◽

Randomized Controlled

Download Full-text

Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes

Endocrinology and Metabolism ◽

10.3803/enm.2019.34.4.382 ◽

2019 ◽

Vol 34 (4) ◽

pp. 382 ◽

Cited By ~ 2

Author(s):

Han Na Jang ◽

Ye Seul Yang ◽

Seong Ok Lee ◽

Tae Jung Oh ◽

Bo Kyung Koo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Aspart ◽

Basal Insulin ◽

Insulin Degludec ◽

Once Daily ◽

Daily Insulin

Download Full-text

Better Glycemic Control and Less Weight Gain with Once Weekly Dulaglutide vs. Once Daily Insulin Glargine, Both Combined with Pre-Meal Insulin Lispro, in Type 2 Diabetes Patients (AWARD-4)

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2014.07.136 ◽

2014 ◽

Vol 38 (5) ◽

pp. S50 ◽

Cited By ~ 2

Author(s):

Johan Jendle ◽

Julio Rosenstock ◽

Lawrence Blonde ◽

Vincent Woo ◽

Jorge Gross ◽

...

Keyword(s):

Type 2 Diabetes ◽

Weight Gain ◽

Glycemic Control ◽

Insulin Glargine ◽

Insulin Lispro ◽

Once Daily ◽

Daily Insulin ◽

Diabetes Patients

Download Full-text

Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study

Endocrine Journal ◽

10.1507/endocrj.ej19-0179 ◽

2019 ◽

Vol 66 (8) ◽

pp. 745-752

Author(s):

Seiya Shimoda ◽

Wakana Sakamoto ◽

Ayaka Hokamura ◽

Yasuto Matsuo ◽

Taiji Sekigami ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

Controlled Study ◽

Efficacy And Safety ◽

Once Daily ◽

Randomized Controlled ◽

Japanese Adults ◽

Long Acting

Download Full-text